Canada Markets close in 5 hrs 56 mins

CareDx, Inc (CDNA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.01+0.06 (+0.46%)
As of 10:04AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close12.95
Open12.94
Bid13.00 x 800
Ask12.99 x 1000
Day's Range12.65 - 13.17
52 Week Range11.92 - 47.82
Volume68,733
Avg. Volume944,345
Market Cap686.957M
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance

    BRISBANE, Calif., December 01, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the results of a new study published in Transplantation Direct1 which establishes a reference baseline when using AlloSure® Lung in the long-term surveillance of lung transplant patients.

  • Business Wire

    CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community

    BRISBANE, Calif., November 11, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the five-year anniversary of AlloSure®, the groundbreaking, non-invasive donor-derived cell-free DNA (dd-cfDNA) surveillance solution used to measure allograft injury in solid organ transplant recipients. AlloSure along with Allo

  • Business Wire

    CareDx To Participate in Upcoming Investor Conferences

    BRISBANE, Calif., November 04, 2022--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in two upcoming investor conferences.